Chronic Renal Failure (CRF)
Kidneys – The Natural Filters of the Body
Kidneys are two bean-shaped organs situated below the rib cage on either side of the spine. Their primary function is to excrete wastes from the body in the form of urine. Urine is excreted by the filtration of blood by nephrons, the microscopic structural and functional unit of the kidneys. A single kindly can contain up to 1,000,000 nephrons.
Advent of Chronic Renal Failure
Over a long period of time, there might be a slow and progressive loss of kidney functions due to diabetes, high blood pressure, glomerulonephritis and polycystic kidney disease leading to cardiovascular morbidity, premature mortality and reduced Quality of Life. This condition is called Chronic Renal Failure (CRF). CRF is also known as chronic renal disease or chronic kidney disease. CRF eventually leads to permanent kidney failure. As CRF is asymptomatic until later stages, it is often undiagnosed or undetected.
CRF may be more common than diabetes
A research study from 2016 titled – ‘Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis’, suggests the prevalence of CRF stages 1-5 as 13.4% and that of Stages 3-5 as 10.6%. The study suggests that CRF can be more common than diabetes as diabetes has an estimated prevalence of 8.2%.
Markers of CRF
The major markers of CRF are oedema on the body, nausea, increase in the level of serum creatinine and serum urea. The patient starts feeling weak with a decrease in haemoglobin levels and a substantial loss of immunity. The glomerular filtration rate (GFR) is also affected.
Stages of CRF
The GFR rate aids in accessing the advancement of Chronic Renal Failure. Advancement of CRF can be classified into the following stages:
- Stage 1 with normal or high GFR where GFR is greater than 90 millilitres per minute.
- Stage 2 is classified as mild CRF/CKD were GFR is in the range of 60-89 millilitre per minute.
- Stage 3A is classified as moderate CRF/CKD where GFR is in the range of 45-59 millilitre per minute.
- Stage 3B is also classified as moderate CRF/CKD where GFR falls further in the range of 30-44 millilitre per minute.
- Stage 4 is classified as severe CRF/CKD with GFR in the range of 15-29 millilitre per minute.
- Stage 5 is classified as end-stage CRF/CKD with GFR lower than 15 millilitre per minute.
Outcomes of CRF
Untreated CRF in the absence of change in food habits and medical treatment leads to a progressive loss of kidney function, fast reaching to the life-threatening stage. The current treatment is dialysis as per requirement, ranging from once a day to once in several weeks. This does not treat the basic cause but helps in eliminating the wastes accumulated in the blood. Dialysis alone does not provide any remedy to declining haemoglobin, which ultimately becomes a major cause for further deterioration and decrease in immunity.
The composition of Renochlor Formulation
The active molecule Renochlor is Sodium Copper Chlorophyllin. During the synthesis of chlorophyllin, the magnesium atom at the centre of the ring is replaced with copper and the phytol tail is lost. Unlike natural chlorophyll, chlorophyllin is water-soluble. The formulation is not poly-herbal and contains sorbitol and glycerine as adjuvants for better drug delivery.
The composition of Renochlor Formulation
The active molecule Renochlor is Sodium Copper Chlorophyllin.During the synthesis of chlorophyllin, the magnesium atom at the centre of the ring is replaced with copper and the phytol tail is lost. Unlike natural chlorophyll, chlorophyllin is water-soluble. The formulation is not poly-herbal and contains sorbitol and glycerine as adjuvants for better drug delivery.
About Sodium Copper Chlorophyllin
Traditionally Sodium copper chlorophyllin is used as a food colour. It has 21 CFR declaration as safe for human consumption (19862 Federal Register / Vol. 55, No. 82 / Friday, May 21, 1990) and USFDA monograph (19862 Federal Register / Vol. 55, No. 82 / Friday, May 21, 1990 ). In Europe it is acceptable as a safe food additive, Ref no. E140 and is a GRAS Product (Generally recognised as safe)
It is hypothesized that Cu-chlorophyllin molecule shares the same functional structure that of haemoglobin molecule - the porphyrin ring. One end of Cu-chlorophyllin molecule is hydrophilic which can get attached to water like molecules and the other end is hydrophobic which can get attached to lipids. This unique structure allows the Cu-chlorophyllin molecule to dissolve and get into the bloodstream and reach all parts of the body
The porphyrin ring has more affinity towards heavy metals and nephrotoxic elements. The Cu ion in the porphyrin ring is dynamic and when it comes in contact with the heavy metals & toxins the Cu ion gets exchanged for the heavy metals, ions and toxins get attached on the ring thereby getting excreted out of the body.
The result is a decrease in the level of serum creatinine and serum urea which are considered as important markers of the kidney function.
Choose Renochlor for better management of CRF
- There is currently no product in the market similar to Renochlor, though there are a few that are used as adjuvant therapy for CRF.
- Products like Ketosteril and Nefrosteril used for CRF patients are associated with strict lifestyle changes for effectiveness.
- Clinical Trails suggest Renochlor improves Quality of life in CRF patients significantly.
A single arm prospective study comprising of 34 patients, who were administered 3 doses (10 ml per dose) of the formulation for a period of 2 months with a follow-up of no medicine for one month thereafter, was conducted. For all the patients, standard care of the treatment was continued during the follow-up period. Inclusion criteria included CRF non-dialysis patients aged between 18 and 70 years with Serum Creatinine more than 1.8 mg/dL. Assessment of QoL was based on a WHO questionnaire which has been specifically designed for CRF patients.
The primary objective of the trial was to study the efficacy of Syrup Renochlor in reducing Serum Creatinine in CRF patients and the secondary objective was to see the efficacy of Syrup Renochlor in reducing blood urea, increasing haemoglobin and improving Quality of Life (QoL) in CRF patients.
THINQ Pharma group of companies situated in Singapore and Mumbai having a worldwide presence was established in 1989. We are a vertically integrated pharmaceutical company with API’s and Formulation segments and a robust clinical research wing. THINQ Pharma has more than 25 years of experience in the international markets of USA, Singapore, South Africa and South East Asia.
With research of more than 4 years, THINQ has developed a plethora of natural products for enhancing and addressing health and wellness.